Cargando…
A Multicentre Study on the Efficacy, Safety and Pharmacokinetics of IqYmune®, a Highly Purified 10% Liquid Intravenous Immunoglobulin, in Patients with Primary Immune Deficiency
This multicentre, open-label, prospective, single-arm study was designed to evaluate the efficacy, pharmacokinetics, and safety of IqYmune®, a highly purified 10% polyvalent immunoglobulin preparation for intravenous administration in patients with primary immunodeficiency. IqYmune® was administered...
Autores principales: | Krivan, Gergely, Chernyshova, Ludmila, Kostyuchenko, Larysa, Lange, Andrzej, Nyul, Zoltan, Derfalvi, Beata, Musial, Jacek, Bellon, Anne, Kappler, Martin, Sadoun, Alain, Bernatowska, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554475/ https://www.ncbi.nlm.nih.gov/pubmed/28711959 http://dx.doi.org/10.1007/s10875-017-0416-4 |
Ejemplares similares
-
An international multicenter efficacy and safety study of IqYmune in initial and maintenance treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy: PRISM study
por: Nobile‐Orazio, Eduardo, et al.
Publicado: (2020) -
IqYmune® is an effective maintenance treatment for multifocal motor neuropathy: A randomised, double‐blind, multi‐center cross‐over non‐inferiority study vs Kiovig®—The LIME Study
por: Léger, Jean‐Marc, et al.
Publicado: (2018) -
Efficacy and Safety of IQYMUNE®, a Ten Percent Intravenous Immunoglobulin in Adult Patients With Chronic, Primary Immune Thrombocytopenia
por: Rodeghiero, Francesco, et al.
Publicado: (2018) -
Impact of the J Project on progress of primary immunodeficiency care in Ukraine
por: Volokha, Alla, et al.
Publicado: (2021) -
Quality-Related Properties of Equine Immunoglobulins Purified by Different Approaches
por: Mateljak Lukačević, Sanja, et al.
Publicado: (2020)